RARE John Richard Pinion sells $229K worth of shares
Mar 04, 2026, 5:34 AM
0.00%
What does RARE do
Ultragenyx Pharmaceutical, based in Novato, California, focuses on developing therapies for rare genetic diseases and has four approved products, including Crysvita and Mepsevii. The company went public on January 31, 2014, and employs 1,276 people.
John Richard Pinion sold 10,029 shares of RARE on 2 March at $22.80 per share, worth a total of $229K. They now own 110,026 RARE shares, or a 8% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.